Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business

317

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion.

Based on an agreement in principle previously announced by Terumo, Abbott and St Jude Medical on October 18, 2016, Terumo will acquire St Jude Medical’s Angio-Seal and FemoSeal vascular closure product lines and Abbott’s Vado steerable sheath. The total annual sales of the businesses to be acquired is approximately US$268 million.

The acquisition remains subject to antitrust regulatory approvals and successful completion of Abbott’s proposed acquisition of St Jude Medical.